Gingival mesenchymal stem cells as an alternative source to bone marrow mesenchymal stem cells in regeneration of bone defects: In vivo study
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Tissue and Cell
- Vol. 63, 101325
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Large animal models for stem cell therapyStem Cell Research & Therapy, 2013
- Rabbit as an animal model for experimental researchDental Research Journal, 2012
- Bone regeneration: current concepts and future directionsBMC Medicine, 2011
- Treatment of long bone defects and non-unions: from research to clinical practiceCell and tissue research, 2011
- Retracted: Histomorphometric and mineral degradation study of Ossceram®: a novel biphasic B‐tricalcium phosphate, in critical size defects in rabbitsClinical Oral Implants Research, 2011
- Human gingiva-derived mesenchymal stem cells are superior to bone marrow-derived mesenchymal stem cells for cell therapy in regenerative medicineBiochemical and Biophysical Research Communications, 2010
- Mesenchymal Stem Cells Derived from Human Gingiva Are Capable of Immunomodulatory Functions and Ameliorate Inflammation-Related Tissue Destruction in Experimental ColitisThe Journal of Immunology, 2009
- Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture HealingStem Cells, 2009
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006
- The role of collagen in bone strengthOsteoporosis International, 2005